SCHEMBL20885877

SCHEMBL20885877

COc1ccc(-c2ncc(Cc3ccccc3)cc2-c2ccc(C(=O)O)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 1/20 0.52
KDM1A O60341 1/20 0.51
HDAC1 Q13547 1/20 0.51
MALT1 Q9UDY8 1/20 0.51
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP1A2 P05177 1/20 0.47
GLA P06280 1/20 0.47
GAA P10253 1/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
CYP2C19 P33261 1/20 0.47
GFER P55789 1/20 0.47
KMT2A Q03164 1/20 0.47
CHEK1 O14757 1/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
NPC1 O15118 1/20 0.46
POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20885696 0.91 MAP4K4 (0.52) MAP4K4KDM1AHDAC1MALT1KDM4E
SCHEMBL20885652 0.87 MAP4K4 (0.55) MAP4K4KDM1AHDAC1MALT1KDM4E
SCHEMBL20885881 0.86 MALT1 (0.55) MAP4K4KDM1AHDAC1MALT1KDM4E
SCHEMBL20885643 0.85 MAP4K4 (0.53) MAP4K4KDM1AHDAC1MALT1KDM4E
SCHEMBL20885799 0.84 MAP4K4 (0.52) MAP4K4KDM1AHDAC1MALT1KDM4E
SCHEMBL20885808 0.84 MAP4K4 (0.55) MAP4K4KDM1AHDAC1MALT1KDM4E
SCHEMBL20885879 0.84 KDM1A (0.53) MAP4K4KDM1AHDAC1MALT1KDM4E
SCHEMBL20885658 0.83 MAP4K4 (0.51) MAP4K4KDM1AHDAC1MALT1KDM4E
SCHEMBL20885604 0.83 RARB (0.52) MAP4K4KDM1AHDAC1MALT1MEN1
SCHEMBL20885687 0.82 KDM1A (0.52) MAP4K4KDM1AHDAC1MALT1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10752596-B2 Nitrogen-containing heteroaryl compound and pharmaceutical use thereof JAPAN TOBACCO INC. (JP) 2020-08-25 US disclosed
US-20190152926-A1 NITROGEN-CONTAINING HETEROARYL COMPOUND AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2019-05-23 US disclosed
WO-2019069973-A1 NITROGEN-CONTAINING HETEROARYL COMPOUND, AND PHARMACEUTICAL USE THEREOF 日本たばこ産業株式会社 2019-04-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10752596-B2 Nitrogen-containing heteroaryl compound and pharmaceutical use thereof SLC2A9, SLC6A19, SLC5A2 MAP4K4 4128/4885KDM1A 3547/4885HDAC1 2040/4885
US-20190152926-A1 NITROGEN-CONTAINING HETEROARYL COMPOUND AND PHARMACEUTICAL USE THEREOF SLC2A9, SLC6A19, SLC5A2 MAP4K4 4128/4885KDM1A 3547/4885HDAC1 2040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.